Cell Source, Inc. (CLCS) stock
CLCSOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q1 FY2025, quarter ended Mar 31, 2025Last filing: 10-Q on May 14, 2026
$0.49−0.00 (-0.01%)
Close on Oct 19, 2026Market cap $21.99MP/E –Yield –
Earnings
No earnings reports from Cell Source yet
Quarterly results appear here once Cell Source files an earnings release with the SEC (Form 8-K, Item 2.02, or Form 6-K).
See a number that looks wrong?